Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

Glycosylation is a posttranslational modification of proteins playing a major role in cell signalling, immune recognition, and cell-cell interaction because of their glycan branches conferring structure variability and binding specificity to lectin ligands. Aberrant expression of glycan structures a...

Full description

Bibliographic Details
Main Authors: Tuccillo, Franca Maria, de Laurentiis, Annamaria, Palmieri, Camillo, Fiume, Giuseppe, Bonelli, Patrizia, Borrelli, Antonella, Tassone, Pierfrancesco, Scala, Iris, Buonaguro, Franco Maria, Quinto, Ileana, Scala, Giuseppe
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943294/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943294/

Similar Items